Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial and cellular stress pathway components encompass a broad array of signaling networks, such as the Integrated Stress Response (ISR) and the Mitochondrial Unfolded Protein Response (UPRmt), which maintain proteostasis and metabolic balance [1][2]. These pathways are activated by various stimuli, including nutrient deprivation, oxidative stress, and mitochondrial dysfunction, primarily through the phosphorylation of eIF2α or the activation of transcription factors like ATF4 and ATF5 [1][3]. In neurodegenerative diseases like Alzheimer's and Parkinson's, chronic activation of these pathways can lead to persistent translational inhibition and eventual neuronal death [3]. Conversely, in oncology, cancer cells often exploit these stress responses to survive hypoxic and nutrient-poor environments [1]. Pharmacological modulation of these pathways, using agents like ISRIB or NRF2 activators, aims to restore cellular health or induce apoptosis in stressed cells, though systemic toxicity remains a significant challenge due to the fundamental role of these pathways in normal physiology [3][4]. Sources: [1] Pakos-Zebrucka et al. (2016) EMBO Rep; [2] Shpilka & Haynes (2018) Nat Rev Mol Cell Biol; [3] Costa-Mattioli & Walter (2020) Science; [4] Suomalainen & Battersby (2018) Nat Rev Mol Cell Biol.
Modulation of specific signaling nodes within stress pathways, such as inhibiting eIF2α phosphorylation, activating NRF2-mediated antioxidant responses, or modulating mitochondrial proteostasis to restore cellular homeostasis or selectively induce apoptosis in damaged cells.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial and cellular stress pathway components.